AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 62 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7,700,730 | +786.2% | 515,099 | +388.4% | 0.00% | – |
| Q3 2022 | $869,000 | +187.7% | 105,475 | +129.1% | 0.00% | – |
| Q2 2022 | $302,000 | +22.8% | 46,043 | +4.3% | 0.00% | – |
| Q1 2022 | $246,000 | +62.9% | 44,140 | +37.6% | 0.00% | – |
| Q4 2021 | $151,000 | -66.1% | 32,088 | -55.4% | 0.00% | – |
| Q3 2021 | $445,000 | -6.1% | 71,916 | +0.1% | 0.00% | – |
| Q2 2021 | $474,000 | -56.2% | 71,855 | -51.5% | 0.00% | – |
| Q1 2021 | $1,083,000 | +825.6% | 148,032 | +630.4% | 0.00% | – |
| Q4 2020 | $117,000 | +11.4% | 20,266 | +15.0% | 0.00% | – |
| Q3 2020 | $105,000 | -91.7% | 17,619 | -92.8% | 0.00% | – |
| Q2 2020 | $1,259,000 | +2827.9% | 244,411 | +1935.4% | 0.00% | – |
| Q1 2020 | $43,000 | – | 12,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,952,958 | $22,809,000 | 0.60% |
| SECTORAL ASSET MANAGEMENT INC | 1,151,175 | $6,642,000 | 0.47% |
| X-Square Capital, LLC | 75,952 | $438,000 | 0.24% |
| SABBY MANAGEMENT, LLC | 68,092 | $393,000 | 0.08% |
| WealthTrust Axiom LLC | 22,347 | $128,000 | 0.05% |
| Opaleye Management Inc. | 58,800 | $339,000 | 0.04% |
| Trexquant Investment LP | 64,838 | $374,000 | 0.04% |
| PDT Partners, LLC | 60,117 | $347,000 | 0.02% |
| PERSONAL CFO SOLUTIONS, LLC | 13,000 | $75,000 | 0.02% |
| CVI Holdings, LLC | 13,171 | $76,000 | 0.01% |